Activating mutations in Notch1, which cause ligand-independent activation of the receptor and/or inhibit proteasome-mediated receptor turnover, are observed in about 60% of human T-ALL cases [11]. This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.